Invivyd, Inc. (IVVD:NASDAQ) closed at $0.613 on October 23, 2026, up 0.54% on the day. The stock trades 80.0% below its 52-week high of $3.07 and 16.2% above its 52-week low of $0.528. Over the past year, it lost 72.5%. Invivyd, Inc. is part of the Health Care sector.
In 252 trading sessions since October 23, 2025, IVVD closed higher on 109 days (43%). Its best day was September 21, 2026 (+35.10%) and its worst was May 14, 2026 (-21.09%). The stock moved 10% or more in a single session 22 times. It opened at least 5% above the previous day's high 2 times.
Invivyd Inc is a clinical-stage biopharmaceutical company. It is focused on the discovery, development, and commercialization of antibody-based solutions for infectious diseases with pandemic potential. The company is developing antibodies to transcend the limits of naturally occurring immunity and provide superior protection from viral diseases, beginning with COVID-19. The company's lead product candidate, ADG20 is developed for the treatment and prevention of coronavirus disease which has demonstrated clinically meaningful results in global Phase 3 clinical trials against multiple variants of concern for the prevention and treatment of COVID-19.
Find more stocks like IVVD with the Spikes, Gaps, Breakouts and Performance Tracker scanners.
Based on end-of-day data. For information only, not investment advice.